The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail


5.3 milligram(s) Powder and solvent for solution for injection

Pfizer Healthcare IrelandPA0822/128/001

Main Information

Active SubstancesSomatropin
Strength5.3 milligram(s)
Dosage FormPowder and solvent for solution for injection
Licence HolderPfizer Healthcare Ireland
Licence NumberPA0822/128/001

Group Information

ATC CodeH01AC Somatropin and somatropin agonists
H01AC01 somatropin


Licence Issued20/02/1991
Legal statusProduct subject to prescription which may not be renewed (A)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back